A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers

Itopride, a dopamine D2 antagonist and acetylcholinesterase inhibitor, significantly improved symptoms in patients with functional dyspepsia in one phase II randomized trial. However, the mechanisms by which itopride may improve symptoms are unknown. We aimed to compare the effects of two doses of itopride and placebo on gastric volumes, gastric emptying, small bowel transit and satiation in female and male healthy volunteers. Randomized, double-blind, placebo-controlled study evaluated gastric function before and after 7 days of itopride 100 mg (n = 16) or 200 mg (n = 15) or placebo (n = 15) t.i.d. Validated methods were used to study gastric accommodation (single photon emission computed tomography), gastric emptying and orocecal transit and satiation postnutrient challenge. The three arms were comparable with regard to age, gender and body mass index. There were no statistically significant effects of itopride on gastric emptying, orocecal transit, fasting gastric volume, maximum tolerated volume or aggregate symptom score with nutrient drink challenge. Postprandial (PP) change in gastric volume differed in the three groups (P = 0.019): 625[+/-28 (SEM)], 555(+/-26) and 512(+/-33) in placebo, itopride 100 and 200 mg groups, respectively. In healthy subjects, itopride reduced total PP gastric volume without accelerating gastric emptying or significantly altering gastric motor and sensory function in healthy individuals.     

A Biopsy Procedure for Determining Filet and Predicting Whole-Fish Mercury Concentration

Although mercury contamination of fish is a widespread phenomenon, its regional evaluation is hindered by the reluctance of permitting agencies to grant collection permits, problems in securing adequate freezer space, and time to process whole, large fish or filets. We evaluated mercury concentrations in 210 filet biopsies from 65 sites in 12 western states relative to whole-body mercury concentration in the same fish. We found a highly significant relationship (r²=0.96) between biopsy and whole-fish mercury concentrations for 13 piscivorous and nonpiscivorous fish species. We concluded that relative to conventional fish-tissue sampling and analysis procedures for whole fish or filets, the biopsy procedure for mercury in fish tissue is nonlethal, less cumbersome, more likely to be permitted by fisheries agencies, and a precise and accurate means for determining both filet and whole-fish mercury concentrations.